z-logo
Premium
(+)‐Flavipucine, the Missing Member of the Pyridione Epoxide Family of Fungal Antibiotics
Author(s) -
Loesgen Sandra,
Bruhn Torsten,
Meindl Kathrin,
Dix Ina,
Schulz Barbara,
Zeeck Axel,
Bringmann Gerhard
Publication year - 2011
Publication title -
european journal of organic chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.825
H-Index - 155
eISSN - 1099-0690
pISSN - 1434-193X
DOI - 10.1002/ejoc.201100284
Subject(s) - chemistry , circular dichroism , stereochemistry , enantiomer , pyrone , phytophthora infestans , absolute configuration , side chain , biochemistry , organic chemistry , gene , polymer
Abstract From the culture extracts of the endophytic fungus, Phoma sp., isolated from the plant Salsola oppositifolia , five secondary metabolites were isolated and characterized. On biomalt agar medium, the strain produced the known substances chrysophanol ( 1 ) and hypothemycin ( 2 ), while from liquid‐surface fermentations on a glucose/maltose medium, 2,4‐pyridione derivatives were obtained. Interestingly, one of the isolated compounds, flavipucine ( 3a ), showed a positive [ α ] D ; it, thus, was the enantiomer of the known, but configurationally as yet unassigned (–)‐flavipucine ( 3b ). By using quantum‐chemical circular‐dichroism calculations, the absolute configuration of 3a was established. Moreover, the dihydro analog 5 of flavipucine was isolated for the first time. The stereostructures were determined by extensive spectroscopic data analysis, quantum‐chemical circular dichroism calculations, and X‐ray analysis. With the two enantiomeric side‐chain analogues of flavipucine, fruit rot toxin A (FRT‐A) ( 6a ) and the recently published sapinopyridione ( 6b ), the family of four naturally occurring substituted 2,4‐pyridiones has become complete. Compound 3a exhibits antifungal activity against Phytophthora infestans and moderate inhibitory activity against gram‐positive and gram‐negative bacteria.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here